EP Patent
EP1677767A2 — Crystalline form of gamma-aminobutyric acid analog
Assigned to XenoPort Inc · Expires 2006-07-12 · 20y expired
What this patent protects
A crystalline form of a γ-aminobutyric acid analog, and methods of preparing same, are provided.
USPTO Abstract
A crystalline form of a γ-aminobutyric acid analog, and methods of preparing same, are provided.
Drugs covered by this patent
- Horizant (GABAPENTIN ENACARBIL) · Azurity
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.